Turner Investments’s Rigel Pharmaceuticals RIGL Stock Holding History

Turner Investments’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-28,502	Closed	-$864K	–	250
2015 Q4	$864K	Hold	28,502	–	–	0.18%	154
2015 Q3	$704K	Hold	28,502	–	–	0.14%	175
2015 Q2	$915K	Buy	28,502 +5,014	+21%	+$192K	0.17%	181
2015 Q1	$839K	Buy	+23,488	New	+$644K	0.15%	175
2014 Q3	–	Sell	-14,949	Closed	-$543K	–	564
2014 Q2	$543K	Sell	14,949 -14,591	-49%	-$496K	0.02%	418
2014 Q1	$1.15M	Buy	29,540 +13,083	+79%	+$466K	0.03%	444
2013 Q4	$470K	Buy	+16,457	New	+$483K	0.01%	497

Other funds holding RIGL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Turner Investments's RIGL Position: Q1 2016 in Review

Turner Investments sold out of Rigel Pharmaceuticals (RIGL) in Q1 2016, closing a stake of 28,502 shares — an estimated $864K sold.

Turner Investments first reported a position in RIGL in Q4 2013 and held it in 7 quarters. The position peaked at $1.15M in Q1 2014. 120 funds tracked by Wall St. Rank hold RIGL as of Q1 2016.

Turner Investments reported no remaining Rigel Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Turner Investments sold 28,502 Rigel Pharmaceuticals shares in Q1 2016, an estimated $864K.
Turner Investments first reported a position in Rigel Pharmaceuticals in Q4 2013 and held it in 7 quarters.
Turner Investments's Rigel Pharmaceuticals position peaked at $1.15M in Q1 2014.
120 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2016.

Based on Turner Investments's 13F filing for Q1 2016, filed 13 May 2016.